Goodrx Holdings Inc-Class A

Doximity shares tumbled 19% after hours as its fiscal 2027 revenue forecast of $664-$676 million fell well short of Wall Street estimates, overshadowing strong AI adoption metrics.

Hims & Hers Health reports Q1 earnings Monday after close, with Wall Street expecting ~$617M revenue. The key focus: how its weight-loss business performs after shifting from compounded GLP-1 drugs to FDA-approved options from Novo Nordisk.